Ralph Lippe is an experienced Scientific Director with over 14 years in medical affairs within the pharmaceutical industry, specializing in immunology. They have a strong track record in local, regional, and global medical affairs, successfully leading the launch preparations for multiple drug classes and label extensions, including Enbrel and Xeljanz. Ralph has also managed regulatory filings and led cross-functional project teams across various countries, demonstrating strong intercultural and interdisciplinary skills. They hold a License to Practice Pharmacy and a doctorate in Immunology from the University of Münster. Currently, Ralph serves as the Global Risankizumab PsA Lead in Global Medical Affairs at AbbVie.
This person is not in the org chart
This person is not in any teams
This person is not in any offices